再生医療の世界市場

◆英語タイトル:Regenerative Medicine - Global Market Outlook (2015-2022)
◆商品コード:SMRC65174
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年4月
◆ページ数:125
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥473,100見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥598,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、再生医療の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・再生医療の世界市場:技術別分析/市場規模
・再生医療の世界市場:用途別分析/市場規模
・再生医療の世界市場:地域別分析/市場規模
・再生医療のアメリカ市場規模予測
・再生医療のヨーロッパ市場規模予測
・再生医療のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Regenerative Medicine Market is estimated at $20.07 billion in 2015 and is projected to reach $101.3 billion by 2022 growing at a CAGR of 26.0% from 2015 to 2022. Growing research applications, growing demand in tissue engineering, biomaterials and stem cell therapy systems are some of the factors driving the market growth. However, high cost associated with biomaterials will be a major factor to restrict the market growth. The stem cells application and advancements in nanotechnology will further drive the market over the forecast period.
Gene therapies segment is expected to be the fastest emerging technology due to tremendous potential of gene therapy in minimizing immune rejections, which commonly occur after transplantations. Asia-Pacific would be the fastest growing region for regenerative medicine market. Europe and North America together accounted for over 3/4th of the market revenue and anticipated to be most profitable regional market.

Some of the key players in the market include Shire Pharmaceuticals, Advanced Cell Technology, Inc, Genzyme, Athersys, Inc., Kinetic Concepts, Inc., NuVasive Inc., Stem cells, Inc., Cytori Therapeutics, Inc., Cytomedix Inc., Mesoblast Ltd. , Zimmer Holdings, Inc., Orthofix, DePuy Synthes Inc., Cell Medica and CryoLife.

Technologies Covered:
• Small Molecules and Biologics
• Gene Therapy
• Cell Therapy

Applications Covered:
• Dermatology
• Cardiovascular Disorders
• Central Nervous System (CNS)
• Orthopedic
• Dental
• Other applications
o Autoimmune Diseases
o Muscle Regeneration
o Ocular Diseases
o Internal organ regeneration

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Regenerative Medicine Market, By Technology
5.1 Introduction
5.2 Small Molecules and Biologics
5.3 Gene Therapy
5.4 Cell Therapy

6 Global Regenerative Medicine Market, By Applications
6.1 Introduction
6.2 Dermatology
6.3 Cardiovascular Disorders
6.4 Central Nervous System (CNS)
6.5 Orthopedic
6.6 Dental
6.7 Other Applications
6.7.1 Autoimmune Diseases
6.7.2 Muscle regeneration
6.7.3 Ocular Diseases
6.7.4 Internal organ regeneration

7 Global Regenerative Medicine Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Shire Pharmaceuticals
9.2 Advanced Cell Technology, Inc
9.3 Genzyme
9.4 Athersys, Inc.
9.5 Kinetic Concepts, Inc.
9.6 NuVasive Inc.
9.7 Stem cells, Inc.
9.8 Cytori Therapeutics, Inc.
9.9 Cytomedix Inc.
9.10 Mesoblast Ltd.
9.11 Zimmer Holdings, Inc.
9.12 Orthofix
9.13 DePuy Synthes, Inc.
9.14 Cell Medica
9.15 CryoLife

List of Tables
Table 1 Global Regenerative Medicine Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Regenerative Medicine Market Outlook, By Technology (2014-2022) ($MN)
Table 3 Global Regenerative Medicine Market Outlook, By Small Molecules and Biologics (2014-2022) ($MN)
Table 4 Global Regenerative Medicine Market Outlook, By Gene Therapy (2014-2022) ($MN)
Table 5 Global Regenerative Medicine Market Outlook, By Cell Therapy (2014-2022) ($MN)
Table 6 Global Regenerative Medicine Market Outlook, By Applications (2014-2022) ($MN)
Table 7 Global Regenerative Medicine Market Outlook, By Dermatology (2014-2022) ($MN)
Table 8 Global Regenerative Medicine Market Outlook, By Cardiovascular Disorders (2014-2022) ($MN)
Table 9 Global Regenerative Medicine Market Outlook, By Central Nervous System (CNS) (2014-2022) ($MN)
Table 10 Global Regenerative Medicine Market Outlook, By Orthopedic (2014-2022) ($MN)
Table 11 Global Regenerative Medicine Market Outlook, By Dental (2014-2022) ($MN)
Table 12 Global Regenerative Medicine Market Outlook, By Other Applications (2014-2022) ($MN)
Table 13 Global Regenerative Medicine Market Outlook, By Autoimmune Diseases (2014-2022) ($MN)
Table 14 Global Regenerative Medicine Market Outlook, By Muscle regeneration (2014-2022) ($MN)
Table 15 Global Regenerative Medicine Market Outlook, By Ocular Diseases (2014-2022) ($MN)
Table 16 Global Regenerative Medicine Market Outlook, By Internal organ regeneration (2014-2022) ($MN)
Table 18 North America Regenerative Medicine Market Outlook, By Technology (2014-2022) ($MN)
Table 19 North America Regenerative Medicine Market Outlook, By Small Molecules and Biologics (2014-2022) ($MN)
Table 20 North America Regenerative Medicine Market Outlook, By Gene Therapy (2014-2022) ($MN)
Table 21 North America Regenerative Medicine Market Outlook, By Cell Therapy (2014-2022) ($MN)
Table 22 North America Regenerative Medicine Market Outlook, By Applications (2014-2022) ($MN)
Table 23 North America Regenerative Medicine Market Outlook, By Dermatology (2014-2022) ($MN)
Table 24 North America Regenerative Medicine Market Outlook, By Cardiovascular Disorders (2014-2022) ($MN)
Table 25 North America Regenerative Medicine Market Outlook, By Central Nervous System (CNS) (2014-2022) ($MN)
Table 26 North America Regenerative Medicine Market Outlook, By Orthopedic (2014-2022) ($MN)
Table 27 North America Regenerative Medicine Market Outlook, By Dental (2014-2022) ($MN)
Table 28 North America Regenerative Medicine Market Outlook, By Others (2014-2022) ($MN)
Table 29 North America Regenerative Medicine Market Outlook, By Autoimmune Diseases (2014-2022) ($MN)
Table 30 North America Regenerative Medicine Market Outlook, By Muscle regeneration (2014-2022) ($MN)
Table 31 North America Regenerative Medicine Market Outlook, By Ocular Diseases (2014-2022) ($MN)
Table 32 North America Regenerative Medicine Market Outlook, By Internal organ regeneration (2014-2022) ($MN)
Table 34 Europe Regenerative Medicine Market Outlook, By Technology (2014-2022) ($MN)
Table 35 Europe Regenerative Medicine Market Outlook, By Small Molecules and Biologics (2014-2022) ($MN)
Table 36 Europe Regenerative Medicine Market Outlook, By Gene Therapy (2014-2022) ($MN)
Table 37 Europe Regenerative Medicine Market Outlook, By Cell Therapy (2014-2022) ($MN)
Table 38 Europe Regenerative Medicine Market Outlook, By Applications (2014-2022) ($MN)
Table 39 Europe Regenerative Medicine Market Outlook, By Dermatology (2014-2022) ($MN)
Table 40 Europe Regenerative Medicine Market Outlook, By Cardiovascular Disorders (2014-2022) ($MN)
Table 41 Europe Regenerative Medicine Market Outlook, By Central Nervous System (CNS) (2014-2022) ($MN)
Table 42 Europe Regenerative Medicine Market Outlook, By Orthopedic (2014-2022) ($MN)
Table 43 Europe Regenerative Medicine Market Outlook, By Dental (2014-2022) ($MN)
Table 44 Europe Regenerative Medicine Market Outlook, By Others (2014-2022) ($MN)
Table 45 Europe Regenerative Medicine Market Outlook, By Autoimmune Diseases (2014-2022) ($MN)
Table 46 Europe Regenerative Medicine Market Outlook, By Muscle regeneration (2014-2022) ($MN)
Table 47 Europe Regenerative Medicine Market Outlook, By Ocular Diseases (2014-2022) ($MN)
Table 48 Europe Regenerative Medicine Market Outlook, By Internal organ regeneration (2014-2022) ($MN)
Table 50 Asia Pacific Regenerative Medicine Market Outlook, By Technology (2014-2022) ($MN)
Table 51 Asia Pacific Regenerative Medicine Market Outlook, By Small Molecules and Biologics (2014-2022) ($MN)
Table 52 Asia Pacific Regenerative Medicine Market Outlook, By Gene Therapy (2014-2022) ($MN)
Table 53 Asia Pacific Regenerative Medicine Market Outlook, By Cell Therapy (2014-2022) ($MN)
Table 54 Asia Pacific Regenerative Medicine Market Outlook, By Applications (2014-2022) ($MN)
Table 55 Asia Pacific Regenerative Medicine Market Outlook, By Dermatology (2014-2022) ($MN)
Table 56 Asia Pacific Regenerative Medicine Market Outlook, By Cardiovascular Disorders (2014-2022) ($MN)
Table 57 Asia Pacific Regenerative Medicine Market Outlook, By Central Nervous System (CNS) (2014-2022) ($MN)
Table 58 Asia Pacific Regenerative Medicine Market Outlook, By Orthopedic (2014-2022) ($MN)
Table 59 Asia Pacific Regenerative Medicine Market Outlook, By Dental (2014-2022) ($MN)
Table 60 Asia Pacific Regenerative Medicine Market Outlook, By Others (2014-2022) ($MN)
Table 61 Asia Pacific Regenerative Medicine Market Outlook, By Autoimmune Diseases (2014-2022) ($MN)
Table 62 Asia Pacific Regenerative Medicine Market Outlook, By Muscle regeneration (2014-2022) ($MN)
Table 63 Asia Pacific Regenerative Medicine Market Outlook, By Ocular Diseases (2014-2022) ($MN)
Table 64 Asia Pacific Regenerative Medicine Market Outlook, By Internal organ regeneration (2014-2022) ($MN)
Table 66 Rest of the World Regenerative Medicine Market Outlook, By Technology (2014-2022) ($MN)
Table 67 Rest of the World Regenerative Medicine Market Outlook, By Small Molecules and Biologics (2014-2022) ($MN)
Table 68 Rest of the World Regenerative Medicine Market Outlook, By Gene Therapy (2014-2022) ($MN)
Table 69 Rest of the World Regenerative Medicine Market Outlook, By Cell Therapy (2014-2022) ($MN)
Table 70 Rest of the World Regenerative Medicine Market Outlook, By Applications (2014-2022) ($MN)
Table 71 Rest of the World Regenerative Medicine Market Outlook, By Dermatology (2014-2022) ($MN)
Table 72 Rest of the World Regenerative Medicine Market Outlook, By Cardiovascular Disorders (2014-2022) ($MN)
Table 73 Rest of the World Regenerative Medicine Market Outlook, By Central Nervous System (CNS) (2014-2022) ($MN)
Table 74 Rest of the World Regenerative Medicine Market Outlook, By Orthopedic (2014-2022) ($MN)
Table 75 Rest of the World Regenerative Medicine Market Outlook, By Dental (2014-2022) ($MN)
Table 76 Rest of the World Regenerative Medicine Market Outlook, By Others (2014-2022) ($MN)
Table 77 Rest of the World Regenerative Medicine Market Outlook, By Autoimmune Diseases (2014-2022) ($MN)
Table 78 Rest of the World Regenerative Medicine Market Outlook, By Muscle regeneration (2014-2022) ($MN)
Table 79 Rest of the World Regenerative Medicine Market Outlook, By Ocular Diseases (2014-2022) ($MN)
Table 80 Rest of the World Regenerative Medicine Market Outlook, By Internal organ regeneration (2014-2022) ($MN)



【レポートのキーワード】

再生医療、生物製剤、小分子、遺伝子治療、細胞治療

★調査レポート[再生医療の世界市場]販売に関する免責事項
★調査レポート[再生医療の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆